These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18212620)

  • 1. Six consecutive cases of successful adult ABO-incompatible living donor liver transplantation: a proposal for grading the severity of antibody-mediated rejection.
    Morioka D; Togo S; Kumamoto T; Takeda K; Matsuo K; Inayama Y; Yamanaka S; Tanaka K; Endo I; Maegawa J; Shimada H
    Transplantation; 2008 Jan; 85(2):171-8. PubMed ID: 18212620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
    Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
    Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis in ABO incompatible liver transplantation: a clinicohistological evaluation of four patients.
    Takeda K; Tanaka K; Morioka D; Kumamoto T; Endo I; Togo S; Shimada H
    Clin Transplant; 2010; 24(6):747-51. PubMed ID: 19925462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
    Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
    Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immunomodulation in ABO-incompatible adult liver transplant recipients.
    Urbani L; Mazzoni A; Bianco I; Grazzini T; De Simone P; Catalano G; Montin U; Petruccelli S; Morelli L; Campani D; Pollina L; Biancofiore G; Bindi L; Tascini C; Menichetti F; Scatena F; Filipponi F
    J Clin Apher; 2008; 23(2):55-62. PubMed ID: 18186527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation.
    Haga H; Egawa H; Shirase T; Miyagawa A; Sakurai T; Minamiguchi S; Yamabe H; Manabe T; Tanaka K
    Liver Transpl; 2004 Jan; 10(1):16-27. PubMed ID: 14755773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange conditioning for ABO-incompatible renal transplantation.
    Winters JL; Gloor JM; Pineda AA; Stegall MD; Moore SB
    J Clin Apher; 2004; 19(2):79-85. PubMed ID: 15274200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange.
    Kawagishi N; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satomi S
    Transplant Proc; 2005 Mar; 37(2):1205-6. PubMed ID: 15848670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
    Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
    Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
    Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
    Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intraportal donor-specific leukocyte transfusion for adult ABO-incompatible liver transplantation.
    Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Hara Y; Kokai H; Hatakeyama K
    Transplant Proc; 2009; 41(1):222-5. PubMed ID: 19249519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation.
    Egawa H; Oike F; Buhler L; Shapiro AM; Minamiguchi S; Haga H; Uryuhara K; Kiuchi T; Kaihara S; Tanaka K
    Transplantation; 2004 Feb; 77(3):403-11. PubMed ID: 14966415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
    Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
    Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
    Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.